Taken together, these results suggest that SLC3A2 may enhance the metabolism of tumor cells, thereby affecting the function of cytokines and the infiltration of immune cells into nasopharyngeal carcinoma tissues, and ultimately promote the progression of tumor. Here, SLC3A2 is linked to neoplasm.